Drug intelligence / Profile preview

methylcobalamin + pyridoxine + folic acid + cholecalciferol

Development stage
Unknown
Lead developer
Solis Pharms
Modality
Small Molecules
Administration
Oral
01

Overview

Welfol-D3 is an oral combination pharmaceutical product developed by Solis Pharms, containing methylcobalamin (1500 mcg), pyridoxine (20 mg), folic acid (5 mg), and cholecalciferol (2000 IU). This formulation is designed to address nutritional deficiencies and support neurological and bone health. Methylcobalamin, a bioactive form of Vitamin B12, is essential for myelin sheath maintenance and DNA synthesis. Pyridoxine (Vitamin B6) serves as a critical cofactor in neurotransmitter synthesis and amino acid metabolism. Folic acid (Vitamin B9) is vital for nucleotide biosynthesis and the regulation of homocysteine levels. Cholecalciferol (Vitamin D3) promotes calcium absorption and bone mineralization by activating the Vitamin D receptor. The product is primarily indicated for the management of peripheral neuropathy, megaloblastic anemia, and vitamin D deficiency.

Brand names
Welfol-D3Welfol-D-3Welfol-D 3
Other names
Methylcobalamin 1500, Pyridoxine 20mg, Folic Acid 5mg and Cholecalciferol 2000 in Tablets
02

Targets

DHFR (Dihydrofolate reductase)VDR (Vitamin D receptor)MTR (Methionine synthase)

Beyond the preview

Go deeper on methylcobalamin + pyridoxine + folic acid + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin + pyridoxine + folic acid + cholecalciferol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call